WASHINGTON, D.C., Jan. 16, 2024 (GLOBE NEWSWIRE) -- Artificial intelligence (AI) has the potential to detect rheumatic heart disease (RHD)…
AndyJanuary 16, 2024
GERMANTOWN, Md., Jan. 16, 2024 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative…
AndyJanuary 16, 2024
ROCKVILLE, Md., Jan. 15, 2024 /PRNewswire/ -- NeoImmuneTech, Inc. (NIT or "NeoImmuneTech"), a clinical-stage T cell-focused biopharmaceutical company, today announces the appointment…
AndyJanuary 16, 2024
January 9, 2024 / By Clary Estes - National wastewater viral activity levels for COVID-19 have been very high since December. (It wasn’t your imagination that…
AndyJanuary 15, 2024
GAITHERSBURG, Md., Jan. 11, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has secured an indefinite-delivery, indefinite-quantity (IDIQ) procurement contract…
AndyJanuary 11, 2024
Acquisition expands GSK’s respiratory pipeline adding AIO-001, a phase II-ready, long-acting antibody targeting the clinically validated TSLP pathway AIO-001 could…
AndyJanuary 10, 2024
KeifeRx is currently advancing programs investigating KFRX03, KFRX04, KFXR05 and KFX06 in neurodegenerative, neuroinflammatory, and mast cell-associated diseases WASHINGTON, Jan. 8,…
AndyJanuary 9, 2024
ROCKVILLE, Md., Jan. 8, 2024 /PRNewswire/ -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) ("Shuttle Pharma") today announced they have received the 'Safe to…
AndyJanuary 9, 2024
New Business Unit Veridix AI Launched to Embed Technology and AI in Day-to-Day Clinical Operations Dr. Rama Kondru to Join…
AndyJanuary 9, 2024